Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Assets (2020 - 2024)

RAPT Therapeutics' Assets history spans 5 years, with the latest figure at $108.5 million for Q3 2024.

  • For Q3 2024, Assets fell 45.69% year-over-year to $108.5 million; the TTM value through Sep 2024 reached $108.5 million, down 45.69%, while the annual FY2023 figure was $173.3 million, 34.89% down from the prior year.
  • Assets for Q3 2024 was $108.5 million at RAPT Therapeutics, down from $127.2 million in the prior quarter.
  • Across five years, Assets topped out at $266.2 million in Q4 2022 and bottomed at $105.9 million in Q1 2021.
  • The 5-year median for Assets is $187.5 million (2022), against an average of $179.5 million.
  • The largest annual shift saw Assets soared 77.06% in 2022 before it tumbled 45.69% in 2024.
  • A 5-year view of Assets shows it stood at $119.0 million in 2020, then skyrocketed by 66.96% to $198.6 million in 2021, then soared by 34.02% to $266.2 million in 2022, then plummeted by 34.89% to $173.3 million in 2023, then tumbled by 37.42% to $108.5 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Assets are $108.5 million (Q3 2024), $127.2 million (Q2 2024), and $155.8 million (Q1 2024).